Laboratory Products 87
New Mixer Mill Processes 2 to 50 Samples in One Batch
New Clinical MDR and Study Automation Platform Accelerates Clinical Trial Design and Build
Formedix announces the launch of ryze, an innovative all-in-one cloud-based clinical metadata repository (MDR) and study automation platform. ryze has been specifi cally developed to accelerate and streamline the design, build and submission of clinical trials, in compliance with the Clinical Data Interchange Standards Consortium (CDISC) and NCI Controlled Terminology.
With the new Mixer Mill MM 500 vario, Retsch has developed a versatile bench-top unit which provides ultimate performance with maximum fl exibility for your sample preparation process. It is used for dry, wet and cryogenic grinding of small sample volumes with high throughput.
The MM 500 vario can be equipped with up to six screw-top grinding jars from 1.5 ml to 50 ml. For biological applications, such as homogenisation of plants or tissues or for cell disruption via bead beating, the MM 500 vario accommodates different adapters for single-use vials from 0.2 - 5 ml.
Beside routine applications which require high sample throughput and quick pulverisation in less than 2 min, the MM 500 vario is perfectly suited for long- term grindings of several hours with high energy input e. g. for mechanical alloying or chemical reactions.
On top of high throughput and variability, the machine provides high energy input with its maximum frequency of 35 Hz, leading to faster grinding results than with other mixer mills with only 30 Hz.
The MM 500 can be controlled via the new optional Retsch App which provides functionalities like creation of application routines, access to the Retsch database or direct contact to the Retsch service team.
More information online:
ilmt.co/PL/JEPB
52200pr@reply-direct.com
Made in
Germany
As a fully-integrated software suite, ryze enables the design and build of the full spectrum of case report forms (CRFs), study data tabulation models (SDTMs) and analysis data models (ADaMs), while also automating SDTM mappings and conversions. Built with compliance at its core, the platform features metadata templates with embedded CDISC standards and NCI Controlled Terminology. This enables pharmaceutical, biotechnology and CRO organisations to effortlessly meet their regulatory objectives. Importantly, ryze facilitates metadata standardisation, expediting clinical trial set up, enabling data reuse, and improving data quality and consistency.
ryze is the only platform that allows seamless integration with a wide selection of leading electronic data capture (EDC) systems, including support for the individual functionality of each system. As such, clinical data professionals can use ryze to design CRFs and make any necessary changes before automatically exporting the designs into the EDC of their choice to build their clinical trial. As a result, clinical trial build can take as little as 6 weeks.
Furthermore, ryze is a commercial off-the-shelf system, meaning it is available for use immediately and can be rapidly confi gured to meet specifi c application needs.
SDTM conversion is enabled at the click of a button, signifi cantly reducing time-to-data and providing clinicians instant visibility of patient data as soon as it starts fl owing in from the EDC system. This allows clinicians to gain actionable data insights to drive well-informed, data-based decision making. Owing to this unique capability, an early release of ryze has already been used with great success to rapidly roll- out COVID-19 vaccine clinical trials.
More information online:
ilmt.co/PL/AEaO 54973pr@reply-direct.com
FORTUNA®
OPTIMAT®
3
Automatic programmable Dispensing Station
Our Poulten & Graf Glass Syringe Selection
We have the solution for your
application! Coming soon :
https://www.poulten-graf.de/shop
www.poulten-graf.de
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196
